Renal nerves: Time for reassessment of their role in hypertension?

American Journal of Hypertension

Volumn 27, Issue 10, 2014, Pages 1245-1247

  Fink, Gregory D ^a   Osborn, John W ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; IRBESARTAN; NORADRENALIN;

ABLATION THERAPY; ALDOSTERONE BLOOD LEVEL; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR SYSTEM EXAMINATION; CATHETER; CATHETER BASED RENAL NERVE ABLATION; FAT INTAKE; HUMAN; HYPERTENSION; KIDNEY DENERVATION; KIDNEY NERVE; KIDNEY VASCULAR RESISTANCE; NOTE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RESISTANT HYPERTENSION; SODIUM ABSORPTION; ADRENERGIC SYSTEM; ANIMAL; CATHETER ABLATION; INNERVATION; KIDNEY; MALE; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; SLEEP DISORDERED BREATHING; SYMPATHECTOMY; VASCULARIZATION;

ANIMALS; BLOOD PRESSURE; CATHETER ABLATION; HYPERTENSION; KIDNEY; MALE; OBESITY; SLEEP APNEA, OBSTRUCTIVE; SYMPATHECTOMY; SYMPATHETIC NERVOUS SYSTEM;

EID: 84986883268     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpu096     Document Type: Note

References (12)

1. Leong KT, Walton A, Krum H. Renal sympathetic denervation for the treatment of refractory hypertension. Annu Rev Med 2014; 65:349-365.
2. DiBona GF, Esler M. Translational medicine: the antihypertensive effect of renal denervation. Am J Physiol Regul Integr Comp Physiol 2010; 298:R245-R253.
3. Schlaich MP, Esler MD, Fink GD, Osborn JW, Euler DE. Targeting the sympathetic nervous system: critical issues in patient selection, efficacy, and safety of renal denervation. Hypertension 2014; 63:426-432.
4. Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL; SYMPLICITY HTN-3 Investigators. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014; 370:1393-1401.
5. Henegar JR, Zhang Y, Rama RD, Hata C, Hall ME, Hall JE. Catheterbased radiorefrequency renal denervation lowers blood pressure in obese hypertensive dogs. Am J Hypertens 2014; 27:1285-1292.
6. Linz D, Mahfoud F, Linz B, Hohl M, Schirmer SH, Wirth KJ, Böhm M. Effect of obstructive respiratory events on blood pressure and renal perfusion in a pig model for sleep apnea. Am J Hypertens 2014; 27:1293-1300.
7. Marcus JA, Pothineni A, Marcus CZ, Bisognano JD. The role of obesity and obstructive sleep apnea in the pathogenesis and treatment of resistant hypertension. Curr Hypertens Rep 2014; 16:4-11.
8. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009; 373:1275-1281.
9. Esler M. The sympathetic system and hypertension. Am J Hypertens 2000; 13:99S-105S.
10. Esler M, Rumantir M, Kaye D, Lambert G. The sympathetic neurobiology of essential hypertension: disparate influences of obesity, stress, and noradrenaline transporter dysfunction? Am J Hypertens 2001; 14:139S-146S.
11. Abboud F, Kumar R. Obstructive sleep apnea and insight into mechanisms of sympathetic overactivity. J Clin Invest 2014; 124:1454-1457.
12. Florczak E, Prejbisz A, Szwench-Pietrasz E, Sliwiński P, Bieleń P, Klisiewicz A, Michałowska I, Warchoł E, Januszewicz M, Kała M, Witkowski A, Wiȩcek A, Narkiewicz K, Somers VK, Januszewicz A. Clinical characteristics of patients with resistant hypertension: the RESIST-POL study. J Hum Hypertens 2013; 27:678-685.